Exhibiting at Thaifex - Anuga Asia 2025

DCH Auriga (Thailand) Limited is a specialized healthcare and pharmaceutical distribution company operating under Dah Chong Hong Holdings, a member of CITIC Pacific. With its headquarters in Bangkok, Thailand, the company is part of a wider regional network encompassing operations across Hong Kong, Macau, China, Singapore, Malaysia, the Philippines, and Taiwan.

Core Business

DCH Auriga focuses on end-to-end supply chain solutions for the healthcare industry, catering to pharmaceutical, biotechnology, medical device, and consumer health companies. Its service portfolio includes warehousing, regulatory compliance, cold chain logistics, commercial support, and inventory management, all tailored to the stringent demands of the healthcare sector.

Product and Service Offerings

• Pharmaceuticals Distribution: Includes branded prescription drugs like Abraxane, Biktarvy, and Descovy.
• Supply Chain Management: Specialized warehousing, last-mile delivery, and value-added services like kitting and relabeling.
• Regulatory Services: Product registration, pharmacovigilance, and importation license support.
• Technology Integration: Proprietary warehouse management systems and digital analytics platforms for real-time inventory visibility.

Specialization and Core USP

DCH Auriga is distinct in its ability to manage a fully compliant cold chain operation with stringent GDP standards. It is one of the first healthcare distributors in Southeast Asia to implement semi-automated intralogistics solutions, improving efficiency and accuracy in high-throughput environments. Their use of SSI SCHAEFER vertical lift systems and automated storage and retrieval systems (AS/RS) in Bangkok highlights their technological edge.

Financials

While individual financials for the Thailand subsidiary are not publicly disclosed, Dah Chong Hong Holdings Limited, its parent company under CITIC Pacific, reported revenues exceeding HKD 60 billion (approx. USD 7.6 billion) in the latest annual report. DCH Auriga, as a division, is one of the key contributors to this figure through its healthcare logistics operations in Asia.

Shipment and Trade Records

According to international trade data platforms like ImportYeti and TradeMo:

• DCH Auriga (Thailand) Limited has engaged in over 1,500 shipments globally in the past 36 months.
• Major destinations include Hong Kong, Singapore, Vietnam, and Malaysia.
• High-value shipments primarily consist of pharmaceutical goods requiring controlled temperature logistics.

Target Market

The company targets:

• Multinational pharmaceutical corporations entering or expanding in Southeast Asia.
• Medical device companies needing regulated warehousing and customs clearance support.
• Healthcare brands seeking last-mile delivery and in-market execution.

Capabilities

• 5,000+ pallet positions of temperature-controlled storage.
• Regulatory specialists with in-depth MOH engagement across ASEAN markets.
• 24/7 temperature monitoring and electronic data logging across fleets.
• Integrated WMS with visibility dashboards for clients.

Certifications and Compliance

• Good Distribution Practice (GDP) certification
• ISO 9001:2015 for quality management systems
• Compliance with Thai FDA and ASEAN harmonized regulations
• Active pharmacovigilance systems (e.g., adverse.events@dchauriga.com)

Customer Testimonials

From SSI SCHAEFER case study:

“The implementation of the vertical lift system by SSI SCHAEFER has significantly increased storage density and picking speed at DCH Auriga Thailand’s flagship distribution center. The solution not only increased efficiency but also ensured compliance with strict industry regulations.”

Major Achievements

• Launched state-of-the-art semi-automated warehouse in Bangkok in 2022, significantly reducing order fulfillment times.
• Named preferred regional distributor by several global pharmaceutical companies including Gilead and Pfizer.
• Successfully managed COVID-19 vaccine storage and distribution across Thailand, meeting stringent cold chain requirements.
• Achieved over 99.5% order accuracy and 98% on-time delivery rate, based on 2023 internal performance audits.